Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell Carcinoma

Gorin, MA; Patel, HD; Rowe, SP; Hahn, NM; Hammers, HJ; Pons, A; Trock, BJ; Pierorazio, PM; Nirschl, TR; Salles, DC; Stein, JE; Lotan, TL; Taube, JM; Drake, CG; Allaf, ME

Allaf, ME (通讯作者),600 North Wolfe St,Pk 223, Baltimore, MD 21287 USA.

EUROPEAN UROLOGY ONCOLOGY, 2022; 5 (1): 113

Abstract

Neoadjuvant immune checkpoint blockade represents a novel approach for potentially decreasing the risk of recurrence in patients with nonmetastatic re......

Full Text Link